Dietary Supplementation of Edible Mushroom Phallus atrovolvatus Aqueous Extract Attenuates Brain Changes in the AppNL−G−F Mouse Model of Alzheimer’s Disease

<b>Background/Objectives:</b> Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive dementia and brain accumulation of Aβ-peptide-containing plaques, gliosis, neuroimmune changes, and neurofibrillary tangles. Mushroom polysaccharides have been previously reported to have anti-neuroinflammation activity through the gut-brain axis. This study aimed to evaluate whether a dietary intervention with <i>Phallus atrovolvatus</i>, a recently identified edible mushroom in Thailand, could have a benefit on gut health and alleviate AD-related changes. <b>Methods:</b> Male and female 6-8-month-old littermate wild-type control (C57BL/6J) and <i>App<sup>NL-G-F</sup></i> mice were randomly assigned to either a control diet or a diet supplemented with mushroom aqueous extract (MAE) for 8 weeks to quantify changes in body weight, intestine, immune cells, short chain fatty acids, brain cytokines, amyloid-β (Aβ) levels, gliosis, and memory. <b>Results:</b> MAE had no adverse effects on gut leakiness and increased pyruvate levels in serum. Splenocyte immune profiling revealed a significant increase in the frequency of IgM<sup>+</sup>, IA_IE<sup>+</sup>, and CD14<sup>+</sup> cells in MAE-administered <i>App<sup>NL-G-F</sup></i>female mice compared to their vehicle controls. <i>App<sup>NL-G-F</sup></i>male mice that received MAE showed a significant increase in the frequency of cytotoxic CD8 T cells within the cervical lymph nodes compared to their wild-type counterparts. Aβ deposition and gliosis were significantly reduced in the hippocampi of the MAE-supplemented <i>App<sup>NL-G-F</sup></i> groups. However, MAE feeding did not alter spatial recognition memory in either sex or genotype compared to their vehicle groups. <b>Conclusions:</b> Our findings demonstrated that the administration of <i>P. atrovolvatus</i> aqueous extract showed neuroprotective potential against AD-related changes in the brain with no adverse impact on gut health and memory.

Authors

Institutions

Publication Details

Journal
Nutrients
Published
2025-05-15
DOI
https://doi.org/10.3390/nu17101677
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dietary Supplementation of Edible Mushroom Phallus atrovolvatus Aqueous Extract Attenuates Brain Changes in the AppNL−G−F Mouse Model of Alzheimer’s Disease

Svetlana A. Golovko, Wasaporn Chanput, Drew R. Seeger, Mikhail Y. Golovko et al.
2 links
Nutrients
Alzheimer's disease research and treatments
article

Dietary Supplementation of Edible Mushroom Phallus atrovolvatus Aqueous Extract Attenuates Brain Changes in the AppNL−G−F Mouse Model of Alzheimer’s Disease

Svetlana A. Golovko, Wasaporn Chanput, Drew R. Seeger, Mikhail Y. Golovko, Suba Nookala, Lalida Rojanathammanee, Colin K. Combs, Raweephorn Kaewsaen
article en

Abstract

<b>Background/Objectives:</b> Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive dementia and brain accumulation of Aβ-peptide-containing plaques, gliosis, neuroimmune changes, and neurofibrillary tangles. Mushroom polysaccharides have been previously reported to have anti-neuroinflammation activity through the gut-brain axis. This study aimed to evaluate whether a dietary intervention with <i>Phallus atrovolvatus</i>, a recently identified edible mushroom in Thailand, could have a benefit on gut health and alleviate AD-related changes. <b>Methods:</b> Male and female 6-8-month-old littermate wild-type control (C57BL/6J) and <i>App<sup>NL-G-F</sup></i> mice were randomly assigned to either a control diet or a diet supplemented with mushroom aqueous extract (MAE) for 8 weeks to quantify changes in body weight, intestine, immune cells, short chain fatty acids, brain cytokines, amyloid-β (Aβ) levels, gliosis, and memory. <b>Results:</b> MAE had no adverse effects on gut leakiness and increased pyruvate levels in serum. Splenocyte immune profiling revealed a significant increase in the frequency of IgM<sup>+</sup>, IA_IE<sup>+</sup>, and CD14<sup>+</sup> cells in MAE-administered <i>App<sup>NL-G-F</sup></i>female mice compared to their vehicle controls. <i>App<sup>NL-G-F</sup></i>male mice that received MAE showed a significant increase in the frequency of cytotoxic CD8 T cells within the cervical lymph nodes compared to their wild-type counterparts. Aβ deposition and gliosis were significantly reduced in the hippocampi of the MAE-supplemented <i>App<sup>NL-G-F</sup></i> groups. However, MAE feeding did not alter spatial recognition memory in either sex or genotype compared to their vehicle groups. <b>Conclusions:</b> Our findings demonstrated that the administration of <i>P. atrovolvatus</i> aqueous extract showed neuroprotective potential against AD-related changes in the brain with no adverse impact on gut health and memory.

NutrientsVol. 17(10)
Kasetsart University (TH), University of North Dakota (US), Suranaree University of Technology (TH)
National Research Council of Thailand, National Institute of General Medical Sciences
Openalex Percentile: Top 86%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.